An assessment of 18 F-FDG PET/CT for thoracic screening and risk stratification of pulmonary nodules in multiple endocrine neoplasia type 1.CONTEXT
 To evaluate fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) for identification and prognostic assessment of thoracic lesions in MEN 1.


 Fifty consecutive MEN 1 patients undergoing screening with 18 F-FDG PET/CT at a tertiary referral hospital between July 2011 and December 2016.


 18 F-FDG PET/CT.


 Thoracic imaging with 18 F-FDG PET/CT effectively identifies pulmonary nodules and ThC. 
PET/CT
An assessment of 18 F-FDG PET/CT for thoracic screening and risk stratification of pulmonary nodules in multiple endocrine neoplasia type 1.CONTEXT
 To evaluate fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) for identification and prognostic assessment of thoracic lesions in MEN 1.


 Fifty consecutive MEN 1 patients undergoing screening with 18 F-FDG PET/CT at a tertiary referral hospital between July 2011 and December 2016.


 18 F-FDG PET/CT.


 Thoracic imaging with 18 F-FDG PET/CT effectively identifies pulmonary nodules and ThC. 
PET/CT
An assessment of 18 F-FDG PET/CT for thoracic screening and risk stratification of pulmonary nodules in multiple endocrine neoplasia type 1.CONTEXT
 To evaluate fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) for identification and prognostic assessment of thoracic lesions in MEN 1.


 Fifty consecutive MEN 1 patients undergoing screening with 18 F-FDG PET/CT at a tertiary referral hospital between July 2011 and December 2016.


 18 F-FDG PET/CT.


 Thoracic imaging with 18 F-FDG PET/CT effectively identifies pulmonary nodules and ThC. 
PET/CT
An assessment of 18 F-FDG PET/CT for thoracic screening and risk stratification of pulmonary nodules in multiple endocrine neoplasia type 1.CONTEXT
 To evaluate fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) for identification and prognostic assessment of thoracic lesions in MEN 1.


 Fifty consecutive MEN 1 patients undergoing screening with 18 F-FDG PET/CT at a tertiary referral hospital between July 2011 and December 2016.


 18 F-FDG PET/CT.


 Thoracic imaging with 18 F-FDG PET/CT effectively identifies pulmonary nodules and ThC. 
PET/CT
An assessment of 18 F-FDG PET/CT for thoracic screening and risk stratification of pulmonary nodules in multiple endocrine neoplasia type 1.CONTEXT
 To evaluate fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) for identification and prognostic assessment of thoracic lesions in MEN 1.


 Fifty consecutive MEN 1 patients undergoing screening with 18 F-FDG PET/CT at a tertiary referral hospital between July 2011 and December 2016.


 18 F-FDG PET/CT.


 Thoracic imaging with 18 F-FDG PET/CT effectively identifies pulmonary nodules and ThC. 
PET/CT